Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-089607
Filing Date
2025-09-12
Accepted
2025-09-12 17:02:30
Documents
23

Document Format Files

Seq Description Document Type Size
1 S-3 tm2525852-1_s3.htm S-3 464118
2 EXHIBIT 4.3 tm2525852d2_ex4-3.htm EX-4.3 3971
3 EXHIBIT 4.7 tm2525852d2_ex4-7.htm EX-4.7 445546
4 EXHIBIT 4.9 tm2525852d2_ex4-9.htm EX-4.9 497816
5 EXHIBIT 5.1 tm2525852d2_ex5-1.htm EX-5.1 31834
6 EXHIBIT 23.1 tm2525852d2_ex23-1.htm EX-23.1 2623
7 EX-FILING FEES tm2525852d1_ex-filingfees.htm   iXBRL EX-FILING FEES 43384
8 GRAPHIC tm2525852d2_ex5-1img001.jpg GRAPHIC 11998
9 GRAPHIC tm2525852d2_ex5-1img002.jpg GRAPHIC 1918
10 GRAPHIC lg_humacyte-4clr.jpg GRAPHIC 10057
11 GRAPHIC tm2525852d2_ex4-3img001.jpg GRAPHIC 333630
12 GRAPHIC tm2525852d2_ex4-3img002.jpg GRAPHIC 179073
  Complete submission text file 0001104659-25-089607.txt   2405367

Data Files

Seq Description Document Type Size
25 EXTRACTED XBRL INSTANCE DOCUMENT tm2525852d1_ex-filingfees_htm.xml XML 14105
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-290231 | Film No.: 251312274
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)